Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
New data show Novartis' Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
Comorbidity is associated with pain-related activity limitations in multiple sclerosis.
Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression.
Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes.
[Treatment for multiple sclerosis in patients with collagen diseases].
Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12.
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study.
Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier.
Skewness of Fractional Anisotropy Detects Decreased White Matter Integrity Resulting From Acute Optic Neuritis.
A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
Factors influencing the desire to provide MS patient care in clinical practice among physiatrists.
Cutaneous Adverse Effects of Neurologic Medications.
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study.
Transcranial Direct Current Stimulation Is Feasible for Remotely Supervised Home Delivery in Multiple Sclerosis.
Grey matter damage in multiple sclerosis: A pathology perspective.
Next-Generation Sequencing Identifies MicroRNAs that Associate with Pathogenic Autoimmune Neuroinflammation in Rats.
Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
Upregulation of voltage-gated Ca(2+) channels in mouse astrocytes infected with Theiler's murine encephalomyelitis virus (TMEV).
Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
Currently Approved And Emerging Oral Therapies In Multiple Sclerosis: An Update For The Ophthalmologist.
Childhood Guillain-Barré syndrome subtypes in northern India.
[Illness, health and sunlight].
Electrophysiological Evaluation of Chronic Inflammatory Demyelinating Polyneuropathy and Charcot-Marie-Tooth Type 1: Dispersion and Correlation Analysis.
Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.
Pages
« first
‹ previous
…
609
610
611
612
613
614
615
616
617
…
next ›
last »